Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2021-10-17', 'size': 222779, 'label': 'Study Protocol', 'hasIcf': False, 'hasSap': False, 'filename': 'Prot_000.pdf', 'typeAbbrev': 'Prot', 'uploadDate': '2021-10-18T17:12', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'OTHER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 10}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-11-04', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-09', 'completionDateStruct': {'date': '2023-01-31', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2023-01-31', 'studyFirstSubmitDate': '2021-09-27', 'studyFirstSubmitQcDate': '2022-05-11', 'lastUpdatePostDateStruct': {'date': '2023-02-01', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2022-05-17', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-12-31', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Standard Usability Score on a Likert Scale', 'timeFrame': 'Procedure duration( aprox 120 min)', 'description': 'The operators completing the intervention will rate the usability of the system on a Likert scale:\n\n1. The HoloLens was useful in this procedure\n2. The HoloLens was not distracting\n3. The HoloLens was comfortable to wear\n4. The HoloLens camera image has sufficient quality for clinical use (not considering the fluoroscopy screen)\n5. Compared to an alternative system with fluoroscopy image plus handsfree voice (telephone), the HoloLens gives additional value during the procedure\n6. The current solution with Remote Assist plus parallel fluoroscopy streaming is mature enough for routine use\n7. The current solution is stable\n8. The current solution is easy to set up prior to the procedure\n9. I would like to continue to use the HoloLens in CTO procedures routinely when remote proctoring is needed\n\nAgree to Disagree Likert Scale\n\n* Strongly Disagree\n* Disagree\n* Neither agree nor disagree\n* Agree\n* Strongly Agree'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Percutaneous Coronary Intervention', 'Chronic Total Occlusion of Coronary Artery']}, 'descriptionModule': {'briefSummary': 'Assess Microsoft HoloLens as an interactive communication device in remote proctoring, and enhancement of teamwork in complex CTO procedures', 'detailedDescription': 'Proctoring in medicine is related to better outcomes. Specifically, in CTO PCI systematic proctoring has demonstrated improved success rates, and an increased ability to treat lesions that are more complex. Most likely, proctoring together with operator volume is one of the foundations to the introduction and execution of CTO procedures. Proctoring traditionally involves an expert operator (proctor), visiting the institution, performing the procedure together with the local operator. This involves increased cost, and current travel restrictions makes traditional one-on-one proctoring challenging.\n\nThis study aims to evaluate the Microsoft HoloLens as a potential platform in proctoring and effective real time communication between PCI operators located at different geographical locations. The proctor and the local operator interact using a head mounted mixed reality (MR) display, enabling the proctor to see the same image as the operator, from any distanced location.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Patients with coronary artery disease and total chronic occlusion of one or more coronary arteries.', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\nClinical inclusion criteria:\n\n* Stable angina pectoris, or dyspnoea as an angina equivalent\n* Age ≥18 yrs.\n* Able to provide written informed consent\n\nAngiographic inclusion criteria:\n\n* One or more completely occluded coronary arteries with Thrombolysis In Myocardial Infarction (TIMI) flow 0. An estimated occlusion duration of at least 3 months\n* Absence of Q-wave in ECG leads corresponding to the occluded vessel, or documented viability of the main territory by MRI or echocardiography\n\nProcedural inclusion criteria:\n\n* Clinical indication for CTO PCI regardless of operative technique\n\nExclusion Criteria:\n\n* STEMI within 72 hours\n* Cardiogenic shock\n* Active bleeding or coagulopathy\n* Life expectancy \\< 2 years\n* Relevant allergies (aspirin, clopidrogrel, ticagrelol, contrast compounds)\n* Severe peripheral artery disease\n* Clinical unstable angina'}, 'identificationModule': {'nctId': 'NCT05377866', 'briefTitle': 'Holo CTO Proctoring Study', 'organization': {'class': 'OTHER_GOV', 'fullName': 'Sorlandet Hospital HF'}, 'officialTitle': 'Holo CTO Proctoring Study', 'orgStudyIdInfo': {'id': 'HoloCTO'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Study population', 'description': 'Patients undergoing percutaneus coronary intervention for chronic total occlusion. The procedures will all be done using mixed reality to enable remote proctoring. The study is a feasibility trial.', 'interventionNames': ['Other: Remote proctoring using HoloLens']}], 'interventions': [{'name': 'Remote proctoring using HoloLens', 'type': 'OTHER', 'otherNames': ['Chronic total occlusion percutaneus coronary intervention'], 'description': 'Assess Microsoft HoloLens as an interactive communication device in remote proctoring, and enhancement of teamwork in complex CTO procedures.', 'armGroupLabels': ['Study population']}]}, 'contactsLocationsModule': {'locations': [{'zip': '4808', 'city': 'Arendal', 'state': 'Agder', 'country': 'Norway', 'facility': 'Sorlandet Hospital', 'geoPoint': {'lat': 58.46151, 'lon': 8.77253}}], 'overallOfficials': [{'name': 'Slobodan Calic, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Sorlandet Hospital'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Sorlandet Hospital HF', 'class': 'OTHER_GOV'}, 'collaborators': [{'name': 'Oslo University Hospital', 'class': 'OTHER'}, {'name': 'HoloCare AS', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}}